(Q37290052)

19 August 2017

1 reference

title

Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis (English)

1 reference

19 August 2017

0 references

Pauline M Camacho

1

1 reference

19 August 2017

Norma A Lopez

series ordinal

2

1 reference

19 August 2017

publication date

1 January 2008

1 reference

Clinical Chemistry and Laboratory Medicine

19 August 2017

published in

1 reference

19 August 2017

volume

46

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

1345-1357

1 reference

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Biological variation in bone-derived biochemical markers in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Molecular basis and clinical application of biological markers of bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Biochemistry of amino acid racemization and clinical application to musculoskeletal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Homocysteine--a newly recognised risk factor for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Biochemical markers of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Relationship of bone turnover to bone density and fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.310

21 January 2018

Identifiers

DOI

10.1515/CCLM.2008.310

1 reference

19 August 2017

1 reference